Isolation Methods for Human CD34 Subsets Using Fluorescent and Magnetic Activated Cell Sorting: an In Vivo...

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Cell Therapy

Background:

• Acute myocardial infarction (AMI) leads to significant cardiac damage and heart failure globally.
• CD34+ cells show promise for treating ischemic heart disease, but optimal isolation methods are unclear.
• Mobilized human peripheral blood mononuclear cells (mhPBMNCs) are a potential source for these therapeutic cells.

Purpose of the Study:

• To compare the efficacy of fluorescence activated cell sorting (FACS) and magnetic beads cell sorting (MACS) for isolating CD34+ cells from mhPBMNCs.
• To evaluate the therapeutic potential of FACS- and MACS-enriched CD34+ cells in a mouse model of myocardial infarction.

Main Methods:

• CD34+ cells were isolated from mhPBMNCs using either FACS or MACS.
• Cell viability, purity, and surface marker expression were assessed via flow cytometry.
• In vivo efficacy was tested in NOD/SCID mice post-myocardial infarction, with intramyocardial transplantation of unselected cells or enriched CD34+ cells.

Main Results:

• Both FACS and MACS yielded high purity and viability of CD34+ cells.
• Transplanted CD34+ cells were retained in the peri-infarct region, promoting angiogenesis and reducing inflammation.
• FACS and MACS groups showed reduced cardiac scarring and fibrosis, leading to improved cardiac function recovery.

Conclusions:

• Cell-based therapy using FACS- or MACS-enriched CD34+ cells significantly improves cardiac recovery post-ischemic injury.
• Both FACS and MACS are effective and comparable methods for CD34+ cell enrichment for clinical applications.
• Enriched CD34+ cell therapy represents a promising strategy for treating myocardial infarction and heart failure.